Industry Reports
Amid Global Setbacks, Indian Pharma Exports Grow In 2021-22
The Government of India recently announced that the pharmaceutical sector had its best-ever export performance in 2021-22, with a phenomenal increase of about $10 billion...
Industry Reports
Samsung Biologics Reports First Quarter 2022 Financial Results
Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for the first quarter of fiscal year 2022.
John Rim, CEO...
Press Releases
Scipio bioscience Announces Its Revolutionary Asteria Single-cell RNA-seq Kit and Companion Cytonaut Analysis Software Are Now Commercially Available
Life Science Newswire – Asteria©, the latest breakthrough single-cell RNA-sequencing kit developed by Scipio bioscience, is now commercially available for any researcher worldwide. This...
News
Omicron Variant Descendants Begin Their Own Coronavirus Wave
The data is undeniable: COVID-19 instances and hospitalizations are on the rise in the United States, despite patchy documentation. Most states are witnessing an upsurge,...
News
Pfizer Holding To $22B Paxlovid Sales Plan Amid Slow Sales
Pfizer officials stated on an earnings call that while Paxlovid's first-quarter sales may seem to be low, there will be plenty more revenues in the...
Press Releases
Paradigm4 Launches Reveal: Proteomics to Transform the Search for Protein Isoform Biomarkers
Paradigm4 has unveiled REVEALTM: Proteomics, the newest use case specific app powered by the Paradigm4 FLASHTM high-performance bioinformatics platform.
REVEAL: Proteomics unlocks the power of...
Press Releases
CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development
CYTENA, a BICO group company and a leading provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















